219 related articles for article (PubMed ID: 33637098)
1. Identification of E2F transcription factor 7 as a novel potential biomarker for oral squamous cell carcinoma.
Zhou P; Xiao L; Xu X
Head Face Med; 2021 Feb; 17(1):7. PubMed ID: 33637098
[TBL] [Abstract][Full Text] [Related]
2. The potential influence of long non-coding RNA PRKG1-AS1 on oral squamous cell carcinoma: A comprehensive study based on bioinformatics and in vitro validation.
Wu T; Zhang SY; Dong WJ; Wang M; Sun YB
J Oral Pathol Med; 2020 May; 49(5):409-416. PubMed ID: 31788859
[TBL] [Abstract][Full Text] [Related]
3. [Expression of Tyrosine Kinase Receptor 2 in Oral Squamous Cell Carcinoma and the Effect on Cell Proliferation and Migration and Epithelial-Mesenchymal Transition Process].
Zheng M; Huang Y; Fei W; Shen Y; Nie X; Gao MY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):342-349. PubMed ID: 36949696
[TBL] [Abstract][Full Text] [Related]
4. Identification of Biological Functions and Prognostic Value of NNMT in Oral Squamous Cell Carcinoma.
Zhang W; Jing Y; Wang S; Wu Y; Sun Y; Zhuang J; Huang X; Chen S; Zhang X; Song Y; Hu Q; Ni Y
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291696
[TBL] [Abstract][Full Text] [Related]
5. FERMT1 knockdown inhibits oral squamous cell carcinoma cell epithelial-mesenchymal transition by inactivating the PI3K/AKT signaling pathway.
Wang X; Chen Q
BMC Oral Health; 2021 Nov; 21(1):598. PubMed ID: 34814915
[TBL] [Abstract][Full Text] [Related]
6. hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p.
Han L; Cheng J; Li A
Cancer Biother Radiopharm; 2021 Feb; 36(1):84-94. PubMed ID: 32302508
[No Abstract] [Full Text] [Related]
7. Baicalin induces ferroptosis in oral squamous cell carcinoma by suppressing the activity of FTH1.
Wen Z; Zhang Y; Gao B; Chen X
J Gene Med; 2024 Feb; 26(2):e3669. PubMed ID: 38380717
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H
J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
[TBL] [Abstract][Full Text] [Related]
9. CD47-SIRPα Signaling Induces Epithelial-Mesenchymal Transition and Cancer Stemness and Links to a Poor Prognosis in Patients with Oral Squamous Cell Carcinoma.
Pai S; Bamodu OA; Lin YK; Lin CS; Chu PY; Chien MH; Wang LS; Hsiao M; Yeh CT; Tsai JT
Cells; 2019 Dec; 8(12):. PubMed ID: 31861233
[TBL] [Abstract][Full Text] [Related]
10. The clinical significance, prognostic value and biological role of lncRNA LINC01793 in oral squamous cell carcinoma.
Yuan SJ; Li SY; Wang YH; Zhang HF; Hua Y; Wang T
Arch Oral Biol; 2021 May; 125():105105. PubMed ID: 33713982
[TBL] [Abstract][Full Text] [Related]
11. Mir-5100 Mediates Proliferation, Migration and Invasion of Oral Squamous Cell Carcinoma Cells Via Targeting SCAI.
Wei Z; Lyu B; Hou D; Liu X
J Invest Surg; 2021 Aug; 34(8):834-841. PubMed ID: 31851859
[TBL] [Abstract][Full Text] [Related]
12. miR-146a promotes proliferation, invasion, and epithelial-to-mesenchymal transition in oral squamous carcinoma cells.
Wang F; Ye LJ; Wang FJ; Liu HF; Wang XL
Environ Toxicol; 2020 Oct; 35(10):1050-1057. PubMed ID: 32469461
[TBL] [Abstract][Full Text] [Related]
13. Expression and mechanism of long non-coding RNA HCG22 in oral squamous cell carcinoma.
Gao YQ; Shi PW; Shi WK; Liu YM
Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Dec; 39(6):658-666. PubMed ID: 34859625
[TBL] [Abstract][Full Text] [Related]
14. Butyrate promotes oral squamous cell carcinoma cells migration, invasion and epithelial-mesenchymal transition.
Zang W; Liu J; Geng F; Liu D; Zhang S; Li Y; Pan Y
PeerJ; 2022; 10():e12991. PubMed ID: 35223210
[TBL] [Abstract][Full Text] [Related]
15. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
[TBL] [Abstract][Full Text] [Related]
16. HMG20A was identified as a key enhancer driver associated with DNA damage repair in oral squamous cell carcinomas.
Na L; Meijie Z; Wenjing Z; Bing Z; Yanhao D; Shanshan L; Yongle Q
BMC Oral Health; 2022 Nov; 22(1):473. PubMed ID: 36335317
[TBL] [Abstract][Full Text] [Related]
17. KLF7 overexpression in human oral squamous cell carcinoma promotes migration and epithelial-mesenchymal transition.
Ding X; Wang X; Gong Y; Ruan H; Sun Y; Yu Y
Oncol Lett; 2017 Apr; 13(4):2281-2289. PubMed ID: 28454392
[TBL] [Abstract][Full Text] [Related]
18. Fibulin-3 sponges Tiam1 to manipulate MMP-7 activity through β-catenin signaling in oral squamous cell carcinoma.
Guo H; Ji Y; Zhang B; Huang X
Med Oncol; 2022 Jul; 39(10):154. PubMed ID: 35852664
[TBL] [Abstract][Full Text] [Related]
19. High ACTN1 Is Associated with Poor Prognosis, and ACTN1 Silencing Suppresses Cell Proliferation and Metastasis in Oral Squamous Cell Carcinoma.
Xie GF; Zhao LD; Chen Q; Tang DX; Chen QY; Lu HF; Cai JR; Chen Z
Drug Des Devel Ther; 2020; 14():1717-1727. PubMed ID: 32440097
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol is an inhibitory polyphenol of epithelial-mesenchymal transition induced by Fusobacterium nucleatum.
Min J; Mashimo C; Nambu T; Maruyama H; Takigawa H; Okinaga T
Arch Oral Biol; 2024 Apr; 160():105897. PubMed ID: 38290225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
